Myriad Genetics | MYGN - Interest Expense On Debt

Stock Price
3.58
Daily Change
-0.04 -1.11%
Monthly
-28.40%
Yearly
-13.32%
Q2 Forecast
3.51

Myriad Genetics reported $4.4M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 2M Dec/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Bio-Rad Laboratories USD 12.1M 200K Dec/2025
Bruker USD 8.1M 11.9M Dec/2025
Danaher USD 63M 8M Mar/2026
Illumina USD 26M 1000K Dec/2025
J&J USD 43M 25M Mar/2026
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.58M 83K Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Veracyte USD 2K 1000 Dec/2023
Waters USD 42M 33.38M Mar/2026